Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
14.08
-0.24 (-1.68%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Mesoblast Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Mesoblast stock has a consensus rating of "Buy" and an average price target of $37. The average 1-year stock price forecast is 162.78% higher than the current stock price, while the lowest is $35 (+148.58%) and the highest is $39 (+176.99%).
Price Target: $37 (+162.78%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mesoblast stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +148.58% | Sep 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $35 → $39 | Buy | Reiterates | $35 → $39 | +176.99% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
191.07M
from 120.25M
Increased by 58.89%
Revenue Next Year
303.67M
from 191.07M
Increased by 58.93%
EPS This Year
-0.01
from -0.04
EPS Next Year
0.08
from -0.01
EPS and Forward PE are based on non-GAAP adjusted numbers.